A Parkinson's Drug Breakthrough
A Parkinson's trial produced an unprecedented result
Aug 11, 2026 · 1 hr 51 min · 19 segments
Dr. David Perlmutter is a board-certified neurologist and New York Times bestselling author known for his work on brain health. Show partners…
David PerlmutterGuestJesse ChappusHostLet's talk about mental health now and the connection between this M1, M2 and how that fits in.

First, I would say that we have, uh, gained an understanding that, uh, many of our mood disorders like, uh, anxiety and, uh, certainly major depressive disorder, have a powerful inflammatory component, and as such we assume therefore that, uh, this is going to shift those microglial cells from M2 to M1.

I mean, there are now, you know, books written, uh, that look-- One is called Brain Energy, that looks at the energetics of what's going on in the brain, in the, in the neurons and in the microglia from an energetic perspective, uh, really focusing on the idea that when we shift away from mitochondrial function, we're setting the stage for increased brain inflammation and polarization away from being helpful of our microglial cells.

Why, why so? Because it takes us out of the realm of being solely dependent upon drugs to realizing that lifestyle interventions may play a role here.

Now, we've known for years that there is m- uh, there can be some significant benefits of lifestyle intervention in patients, for example, with chronic depression, uh, with respect to dietary changes and exercise and paying attention to sleep, for example.

What are the mechanisms? Well, inflammation, uh, improved, uh, uh, insulin sensitivity, uh, increased production of new brain cells, which seems to be something very important in the treatment of depression.

So we move away then from this idea of lack of serotonin is the cause of depression to these other issues that, you know, uh, researchers and clinicians like Dr. Uma Naidoo at, at Harvard, uh, and Christopher Palmer, the author of the book that I just mentioned, have made so clear to us.

And I will re- refer back to a, a earlier part of our discussion where we talked about the imaging of the activated microglial cells, that TSPO imaging, uh, that is seen to be lit up, i.e., microglial cells have shifted from M2 to being destructive M1, as demonstrated by how these TSPO images light up in, uh, major depression, telling us what? This is a shift in the immune function in the brain, and what do we know? We know that that can be brought on by the metabolic changes that we've been talking about
I asked you about now that we have this information, how you look at maybe there being a common thread there.



Why am I emphasizing this? It's because I had an interview the other day with a Dr.


Let's talk about mental health now and the connection between this M1, M2 and how that fits in.

First, I would say that we have, uh, gained an understanding that, uh, many of our mood disorders like, uh, anxiety and, uh, certainly major depressive disorder, have a powerful inflammatory component, and as such we assume therefore that, uh, this is going to shift those microglial cells from M2 to M1.

I mean, there are now, you know, books written, uh, that look-- One is called Brain Energy, that looks at the energetics of what's going on in the brain, in the, in the neurons and in the microglia from an energetic perspective, uh, really focusing on the idea that when we shift away from mitochondrial function, we're setting the stage for increased brain inflammation and polarization away from being helpful of our microglial cells.

Why, why so? Because it takes us out of the realm of being solely dependent upon drugs to realizing that lifestyle interventions may play a role here.

Now, we've known for years that there is m- uh, there can be some significant benefits of lifestyle intervention in patients, for example, with chronic depression, uh, with respect to dietary changes and exercise and paying attention to sleep, for example.

What are the mechanisms? Well, inflammation, uh, improved, uh, uh, insulin sensitivity, uh, increased production of new brain cells, which seems to be something very important in the treatment of depression.

So we move away then from this idea of lack of serotonin is the cause of depression to these other issues that, you know, uh, researchers and clinicians like Dr. Uma Naidoo at, at Harvard, uh, and Christopher Palmer, the author of the book that I just mentioned, have made so clear to us.

And I will re- refer back to a, a earlier part of our discussion where we talked about the imaging of the activated microglial cells, that TSPO imaging, uh, that is seen to be lit up, i.e., microglial cells have shifted from M2 to being destructive M1, as demonstrated by how these TSPO images light up in, uh, major depression, telling us what? This is a shift in the immune function in the brain, and what do we know? We know that that can be brought on by the metabolic changes that we've been talking about
I asked you about now that we have this information, how you look at maybe there being a common thread there.



Why am I emphasizing this? It's because I had an interview the other day with a Dr.


Every episode on Radar is fully transcribed, speaker-labeled, and rich with metadata. Here is a taste of this one. Try Radar for free to see the rest.
3 of 10
A Parkinson's Drug Breakthrough
A Parkinson's trial produced an unprecedented result
The Alzheimer's Drug Challenge
New research challenges Alzheimer's treatment assumptions today
Ultra-Processed Food Dementia Risk
One food habit may reshape dementia risk
+7 more clips · 14 min 9 sec of audio in all
7 of 21
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
All 10 clips — the highlight moments, each cut as its own audio, with a title and a speaker
All 19 segments — the transcript broken into labeled sections, every ad read marked
All 21 topics — jump to every other episode discussing the same subject
Every related episode — other shows Radar links to this one
No account is needed to search Radar.